Emergent BioSolutions Inc (EBS)
2.16
+0.12
(+5.88%)
USD |
NYSE |
Apr 22, 16:00
2.17
+0.01
(+0.46%)
Pre-Market: 20:00
Emergent BioSolutions Cash and Short Term Investments (Quarterly): 111.70M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 111.70M |
| September 30, 2023 | 87.80M |
| June 30, 2023 | 88.60M |
| March 31, 2023 | 430.20M |
| December 31, 2022 | 642.60M |
| September 30, 2022 | 240.90M |
| June 30, 2022 | 358.10M |
| March 31, 2022 | 435.80M |
| December 31, 2021 | 576.10M |
| September 30, 2021 | 403.80M |
| June 30, 2021 | 447.50M |
| March 31, 2021 | 547.80M |
| December 31, 2020 | 621.30M |
| September 30, 2020 | 415.00M |
| June 30, 2020 | 268.80M |
| March 31, 2020 | 181.50M |
| December 31, 2019 | 167.80M |
| September 30, 2019 | 139.20M |
| June 30, 2019 | 177.40M |
| March 31, 2019 | 137.20M |
| December 31, 2018 | 112.20M |
| September 30, 2018 | 339.36M |
| June 30, 2018 | 190.24M |
| March 31, 2018 | 163.61M |
| December 31, 2017 | 178.30M |
| Date | Value |
|---|---|
| September 30, 2017 | 340.99M |
| June 30, 2017 | 315.63M |
| March 31, 2017 | 270.17M |
| December 31, 2016 | 271.51M |
| September 30, 2016 | 298.93M |
| June 30, 2016 | 333.40M |
| March 31, 2016 | 341.02M |
| December 31, 2015 | 308.30M |
| September 30, 2015 | 308.72M |
| June 30, 2015 | 214.84M |
| March 31, 2015 | 216.52M |
| December 31, 2014 | 280.50M |
| September 30, 2014 | 242.25M |
| June 30, 2014 | 168.13M |
| March 31, 2014 | 160.22M |
| December 31, 2013 | 179.34M |
| September 30, 2013 | 172.56M |
| June 30, 2013 | 156.24M |
| March 31, 2013 | 130.24M |
| December 31, 2012 | 141.67M |
| September 30, 2012 | 197.90M |
| June 30, 2012 | 161.84M |
| March 31, 2012 | 150.42M |
| December 31, 2011 | 145.87M |
| September 30, 2011 | 128.84M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
87.80M
Minimum
Sep 2023
642.60M
Maximum
Dec 2022
333.78M
Average
358.10M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Avid Bioservices Inc | 31.42M |
| Viking Therapeutics Inc | 362.08M |
| FibroGen Inc | 235.59M |
| Avinger Inc | 5.275M |
| RAPT Therapeutics Inc | 158.86M |